CD274 and neoplasm: reported that the first patient with last-stage intrahepatic cholangiocarcinoma with PD-L1 positive and high tumor mutation load was successfully eradicated after using tyrosine kinase inhibitors (TKIs) combined with ICIs immunotherapy to shrink the tumor.